TSS
CMD

Two Sigma Securities’s Cantel Medical Corporation CMD Stock Holding History

Two Sigma Securities’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,516
Closed -$259K – 3064
2017
Q4 		$259K Buy
+2,516
New +$251K 0.01% 1105

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Two Sigma Securities's CMD Position: Q1 2018 in Review

Two Sigma Securities sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 2,516 shares — an estimated $259K sold.

Two Sigma Securities first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $259K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Two Sigma Securities reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Securities sold 2,516 Cantel Medical Corporation shares in Q1 2018, an estimated $259K.
  • Two Sigma Securities first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Two Sigma Securities's Cantel Medical Corporation position peaked at $259K in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Two Sigma Securities's 13F filing for Q1 2018, filed 15 May 2018.